PRELUDE CAPITAL MANAGEMENT, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$96,000
+37.1%
11,600
+12.6%
0.00%0.0%
Q4 2020$70,000
-84.2%
10,300
-74.1%
0.00%
-90.5%
Q3 2020$443,000
+41.1%
39,800
-20.6%
0.02%
+23.5%
Q2 2020$314,000
+554.2%
50,100
+92.7%
0.02%
+466.7%
Q1 2020$48,000
-4.0%
26,000
+168.2%
0.00%
-25.0%
Q1 2018$50,000
+35.1%
9,6950.0%0.00%
+33.3%
Q4 2017$37,0009,6950.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders